News of the expanded cost-reduction drive came as Pfizer recorded 1% sales growth to $15 billion, driven by continued strong ...

What does FDA's proposed DTC advertising rule mean for pharm... Last month, the FDA quietly added a proposed rule to the 2026 ...

Pathos AI has added to its pipeline of cancer drugs by licensing a bispecific antibody-drug conjugate (ADC) for solid tumours ...

The criteria developed by UK health technology assessment (HTA) agency NICE to decide who should be referred by GPs for ...

A one-time $5.7 billion charge related to the just-completed $6.7 billion takeover of Terns Pharma and its oral BCR-ABL ...

Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry. A Harvard ...

Expanded APAC expertise, enhanced global infrastructure, and AI-enabled innovation help life sciences organizations generate actionable insights from every scientific interaction. PHILADELPHIA, PA – ...

Novartis paid out $195 million in 2020 to settle a criminal claim brought by the federal government – at the time, the ...

Under the terms of the deal, ‌Lantheus' shareholders will get $102.50 per share in cash when the deal closes, along with the ...

The last mega-mergers between big pharma companies were BMS' $74 billion deal with Celgene in 2019 and the $63 billion AbbVie ...

Sanofi is reported to be preparing a move to take control of US biotech Ocular Therapeutix, after an initial bid was rejected last year. That is according to French newspaper La Lettre, which said ...

Henry Gosebruch, pictured here during his time at Neumora, is replacing Paul Stoffels as CEO of Galapagos. Just a few months after announcing a plan to separate its drug and cell therapy businesses ...